SUBSTITUTED FUSED HETEROCYCLES AS GPR119 MODULATORS FOR THE TREATMENT OF DIABETES, OBESITY, DYSLIPIDEMIA AND RELATED DISORDERS

• 收藏
• 分享

专利权人:

SANOFI

发明人:

Lothar SCHWINK,Christian BUNING,Heiner GLOMBIK,Matthias GOSSEL,Dieter KADEREIT,Nis HALLAND,Matthias LOHMANN,Christoph PÖVERLEIN,Kurt RITTER

申请号：

US15284213

公开号：

US20170022198A1

申请日:

2016.10.03

申请国别(地区):

US

年份:

2017

代理人:

摘要：

The present invention relates to substituted fused heterocyclic compounds.The substituted fused heterocyclic compounds are GPR119 modulators and useful for the prevention and/or treatment of diabetes, obesity, dyslipidemia and related disorders. The invention furthermore relates to the use of substituted fused heterocyclic compounds as active ingredients in pharmaceuticals, and pharmaceutical compositions comprising them.

来源网站：

中国工程科技知识中心

来源网址：

http://www.ckcest.cn/home/